Michael Brian Bell - 01 Oct 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Oct 2024, 16:48:45 UTC
Prior SEC filing
16 Sep 2024
Next SEC filing
12 Nov 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John G. Saia, as attorney-in-fact for Michael Brian Bell

Key filing fact

Michael Brian Bell filed Form 4 for Guardant Health, Inc. (GH) on 02 Oct 2024.

Key facts

  • This page summarizes Michael Brian Bell's Form 4 filing for Guardant Health, Inc. (GH).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 02 Oct 2024, 16:48.

Change

  • Previous filing in this sequence was filed on 16 Sep 2024.
  • Current net transaction value: -$92,063.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GH transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+8,211
Change %
+41%
Price
$0.000000
Shares after
28,237
Date
01 Oct 2024
Ownership
Direct
GH transaction

Common Stock

Tax liability

Transaction value
$92,063
Shares
-4,162
Change %
-15%
Price
$22.12
Shares after
24,075
Date
01 Oct 2024
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-8,211
Change %
-33%
Price
$0.000000
Shares after
16,673
Date
01 Oct 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,211
Exercise price
$0.000000
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Footnote F2

This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Footnote F3

Not applicable for Restricted Stock Units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .